Ozempic and its ilk are inescapable.
While those on the weight loss drug often face more judgment and stigma, it’s undeniable that the medications have had an effect on many people’s health.
As GLP-1 medications continue to evolve and become more popular, they’re having both a major moment and impact in the health landscape.
Drugs like Ozempic show no signs of slowing down, as the number of Americans using the drugs to slim down has more than doubled over the past year and a half
And as prescriptions for the blockbuster GLP-1 drug have risen, obesity rates are falling throughout the population.
Health analytics organization EPIC Research released two new data trackers that show semaglutide — the active ingredient in Ozempic and Wegovy — has had a modest but sustained decrease in the obesity rate.
Read Full Article Here
